Press Release

UAE Regenerative Medicine Market to grow with a CAGR of 25.34%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Regenerative Medicine Market.


According to TechSci Research report, “UAE Regenerative Medicine Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Regenerative Medicine Market has valued at USD 0.13 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 25.34% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

The aging population is a significant driver of the demand for regenerative medicine. Several factors associated with aging contribute to the increasing interest in and utilization of regenerative therapies. Aging is often associated with an elevated risk of osteoarthritis and other orthopedic conditions, leading to joint degeneration and pain. Regenerative medicine, including stem cell therapies and tissue engineering, presents alternatives for managing and potentially reversing the effects of such conditions. Aging can result in a decline in the body's natural healing capacity. Regenerative medicine interventions, such as stem cell treatments and growth factor therapies, aim to enhance the body's regenerative abilities, facilitating more efficient healing and tissue repair. Sarcopenia, the age-related loss of muscle mass and strength, is a common concern among the elderly. Regenerative medicine approaches may contribute to muscle regeneration and functional improvement, addressing issues related to frailty and weakness.

The prevalence of neurodegenerative disorders, such as Alzheimer's and Parkinson's disease, increases with age. Regenerative medicine research explores interventions to repair or replace damaged neural tissues, potentially slowing the progression of these conditions. Aging is a significant risk factor for cardiovascular diseases. Regenerative medicine applications, such as cardiac tissue engineering and stem cell therapies, are being investigated for their potential to repair damaged heart tissues and improve overall cardiac function.


Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Regenerative Medicine Market.


In September 2023, Abu Dhabi is set to initiate a biobank dedicated to stem cell and tissue treatments, with a focus on employing advanced technology and scientific methodologies for addressing over 80 diseases, encompassing conditions such as blood disorders and cancer. The Crown Prince of Abu Dhabi has given his endorsement to utilize human stem cells and tissues in the development of personalized medical research. This approval was granted during a meeting of the Abu Dhabi Executive Council. The forthcoming project aims to establish a biobank that will facilitate the advancement of personalized medicine through innovative treatment programs utilizing human stem cells and tissues for medical research.

Long-term efficacy and safety is crucial considerations and potential challenges in the field of regenerative medicine, including in the UAE. Many regenerative medicine therapies are relatively new, and there may be limited long-term data available on their effectiveness and safety. This lack of comprehensive, extended-term data poses challenges in assessing the sustained efficacy and safety of these treatments. Regenerative medicine often involves complex biological processes, such as stem cell differentiation and tissue regeneration. Understanding the long-term effects of these processes on the body and ensuring their safety over time is a continuing area of research. Interventions in regenerative medicine, particularly those involving genetic modifications, may carry the risk of unintended consequences over the long term. Unanticipated effects on the treated tissues or systemic effects need to be thoroughly investigated to ensure patient safety. Monitoring patients over an extended period to assess the long-term efficacy and safety of regenerative medicine treatments can be challenging. Establishing effective monitoring and surveillance systems is crucial to identify any delayed adverse effects. The use of stem cells, especially pluripotent stem cells, raises concerns about the potential for tumorigenesis or the development of tumors. Ensuring that regenerative therapies do not lead to abnormal cell growth over the long term is a critical safety consideration.


UAE Regenerative Medicine Market is segmented based on Type, Application, End User, and by region.  


Based on the Application, UAE Regenerative Medicine Market is segmented into Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others. Bone graft substitutes are materials used in orthopedic and dental surgeries to replace or augment natural bone tissue. These substitutes aim to promote bone regeneration and healing in cases where bone loss or damage has occurred due to trauma, disease, or other medical conditions. Bone graft substitutes serve as alternatives to traditional bone grafts, which involve taking bone tissue from one part of the patient's body (autograft) or from a donor (allograft). Bone graft substitutes often possess osteoconductive properties, meaning they provide a scaffold or framework for new bone growth. This promotes the migration and attachment of bone-forming cells (osteoblasts) to facilitate the regeneration of bone tissue. Some bone graft substitutes contain osteoinductive factors, which stimulate the differentiation and proliferation of existing cells into bone-forming cells. This enhances the natural bone healing process. Bone graft substitutes are designed to be biocompatible, meaning they are well-tolerated by the body and do not cause adverse reactions. This characteristic is crucial for successful integration with the patient's natural bone.

Based on Region, Abu Dhabi region held the largest share in the UAE Regenerative Medicine Market. The active involvement of the government in promoting regenerative medicine through funding, incentives, and strategic initiatives can significantly impact the market dynamics. Abu Dhabi is a hotspot for clinical trials and innovative research in regenerative medicine, it could attract attention and investment, fostering a dominant market presence. The availability of educational and training programs in regenerative medicine can contribute to the development of a skilled workforce, attracting professionals to the region.

Some of the major companies operating in the UAE Regenerative Medicine Market include:

  • Abu Dhabi Stem Cells Centre
  • Bioscience Clinic Middle East
  • The RegeneSpine Regenerative Spine and Joint Institute
  • Novomed UAE
  • FIFA Medical Center of Excellence

 

Download free Sample Report

Customers can also request 10% free customization on this report.


“Certain areas, particularly in Dubai, are projected to exert significant demand for Regenerative Medicine. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the UAE Regenerative Medicine Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

UAE Regenerative Medicine Market by Type (Cell Therapy, Gene Modification, Tissue Engineering, Others), By Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others), By End User (Academic, Commercial), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE Regenerative Medicine Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE Regenerative Medicine Market.

Contact

Mr. Ken Mathews

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602 

Email: [email protected]

Website: https://www.techsciresearch.com

Relevant News